Breadcrumb Home Machine Learning in Drug Discovery Symposium Agenda 08:00 - 08:50 am Registration/breakfast 08:50 - 09:00 AM Opening Remarks Keynote 09:00 - 10:00 am Machine learning for discovery of translatable targets and biomarkers Daphne Koller CEO and Founder Insitro Morning session 10:00 - 10:40 am Decoding Biology with Data Abundance Imran Haque Senior Vice President, AI and Digital Sciences Recursion 10:40 - 10:55 am Break and poster viewing 10:55 - 11:15 am Lightning talks from selected poster presenters 11:15 - 11:55 am AI in drug discovery – what do we need for being successful? Christoph Grebner Artificial Intelligence Scientist and Computational Chemist Sanofi-Aventis 12:00 - 1:30 pm Lunch and poster viewing Afternoon session 1:30 - 2:10 pm Harnessing AI for Drug Discovery: From Property Prediction to Molecular Design Djork-Arné Clevert Head of Machine Learning Research, Vice President Pfizer 2:10 - 2:30 pm AI-Driven Drug Design: Optimizing Pharmacokinetics and ADME Raquel RodrÃguez Pérez Principal Scientist, Modeling and Simulation Novartis 2:30 - 2:40 pm Break and poster viewing 2:40 - 3:00 pm Automating design of molecules via retrieval augmented generative language models Andrew White Associate Professor University of Rochester 3:00 - 3:20 pm Programmable generative protein design Gevorg Grigoryan CTO, Generate Biomedicines 3:20 - 3:40 pm A tale of two breakthroughs: deep learning for RNA drug design Raphael Townshend CEO, Atomic AI 3:40 pm - 4:00 pm Protpardelle: An All Atom Protein Generative Model Possu Huang Assistant Professor Stanford University 4:00 pm - 4:15 pm Closing remarks AND poster award announcements 4:15 - 6:00 pm Reception and poster session Machine Learning in Drug Discovery Symposium Overview Organizers Advisory Committee Organizing Committee Getting here Archive 2024 Overview Speakers Organizers Advisory Comittee Organizing Committee Agenda Workshop 2023 Overview Agenda Organizers Advisory Comittee Organizing Committee 2022 Organizers Advisory Committee Organizing Committee Latest news News 05.07.2025 How the Novo Nordisk Foundation Center at Ó³»´«Ã½ is using scalable technologies and AI to find the root cause of diabetes News 04.29.2025 Sentinel program among finalists for the $100 Million 100&Change competition News 04.16.2025 WhyIScience Q&A: How a chemist moved to the business side of science News 04.09.2025 Potential Alzheimer’s disease therapeutic target identified in brain immune cells All news
News 05.07.2025 How the Novo Nordisk Foundation Center at Ó³»´«Ã½ is using scalable technologies and AI to find the root cause of diabetes